top of page

We are pioneers in zinc research for brain injury and neurodegenerative disease.

ezgif-55f97d4ccbc6a9.gif

Company Overview

  • Established: March 2020

  • Current Investment: $1.5 M USD from Venture Capitals

  • ​Research Focus

    • Acute Ischemic Brain Injury

    • Neurodegenerative Brain Disease

  • Government-Funded Research Projects

    1. TIPS​(Tech Incubator Program for Startup)

      • Research Area: Multiple Sclerosis (Lead compound)

      • Grant $0.4M USD

      • Duration: July 2021~ June 2023

    2. KDDF​(Korea Drug Development Fund)

      • Research Area: Amyotrophic Lateral Sclerosis(Preclinical candidate)​

      • Grant: $1M USD

      • Duration: April 2023 - March 2025

    3. Asan Bio Core Facility

      • Grant: $0.4M USD

      • Duration: Jan 2025 - Dec 2027

    4. KDDF​(Korea Drug Development Fund)

      • Research Area: Stroke(Preclinical candidate)​

      • Grant: $1M USD

      • Duration: April 2025 - March 2027

  • Collaborations

    • Asan Medical Center

    • Hallym University

    • Harvard Medical School

    • Mercer University

    • Creighton University

#304, Daeyang AI Center, 209 Neungdong-ro, Gwangjin-gu, Seoul

Zincure Corp  | Tel : 02-3408-3648  Email: contact@zincure.com
COPYRIGHT (C) 2020 Zincure  ALL RIGHTS RESERVED

bottom of page